d a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pf
当前文章：http://ee3d1.hengtaoqi.cn/gin3/b7ki5.html
发布时间：06:35:37
